Ingevity Co. (NYSE:NGVT) Shares Bought by Brown Advisory Inc.

Brown Advisory Inc. grew its stake in Ingevity Co. (NYSE:NGVT - Free Report) by 23.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 928,220 shares of the company's stock after acquiring an additional 177,289 shares during the period. Brown Advisory Inc. owned about 2.55% of Ingevity worth $37,825,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. KBC Group NV increased its holdings in Ingevity by 27.5% in the fourth quarter. KBC Group NV now owns 2,007 shares of the company's stock valued at $82,000 after buying an additional 433 shares during the last quarter. Empowered Funds LLC purchased a new position in shares of Ingevity in the 4th quarter valued at about $187,000. O Shaughnessy Asset Management LLC acquired a new stake in shares of Ingevity during the 4th quarter worth about $214,000. Teacher Retirement System of Texas purchased a new stake in Ingevity during the fourth quarter worth approximately $237,000. Finally, Hennion & Walsh Asset Management Inc. acquired a new position in Ingevity in the fourth quarter valued at approximately $239,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Ingevity Stock Performance

Shares of NGVT stock traded up $0.17 during midday trading on Friday, hitting $40.46. The company had a trading volume of 260,803 shares, compared to its average volume of 278,867. Ingevity Co. has a 52-week low of $28.49 and a 52-week high of $56.28. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. The company's 50 day simple moving average is $37.49 and its 200 day simple moving average is $41.90. The stock has a market cap of $1.47 billion, a price-to-earnings ratio of -3.42 and a beta of 1.31.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.99 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.25. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The company had revenue of $284.00 million during the quarter, compared to the consensus estimate of $299.13 million. During the same quarter in the prior year, the firm earned $0.47 EPS. Ingevity's quarterly revenue was down 16.5% on a year-over-year basis. Research analysts anticipate that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently commented on NGVT. Wells Fargo & Company increased their target price on shares of Ingevity from $32.00 to $38.00 and gave the company an "equal weight" rating in a research report on Wednesday. BMO Capital Markets raised Ingevity from a "market perform" rating to an "outperform" rating and boosted their target price for the company from $62.00 to $65.00 in a report on Wednesday, February 26th. Finally, StockNews.com downgraded Ingevity from a "buy" rating to a "hold" rating in a research note on Saturday, April 12th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Ingevity has a consensus rating of "Moderate Buy" and a consensus price target of $52.75.

About Ingevity

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.